SYK
Stryker Corporation
SYK
About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SYK news
Feb 23 10:11am ET Stryker price target raised to $380 from $335 at Argus by TipRanks Feb 21 7:25am ET BTIG medical technology analyst to hold analyst/industry conference call by TipRanks Feb 21 4:55am ET BTIG medical technology analyst to hold analyst/industry conference call by TipRanks Feb 15 12:57pm ET BTIG medical technology analyst to hold analyst/industry conference call by TipRanks Feb 15 8:25am ET Stryker (SYK) Poised for Continued Growth: A Strong Buy Recommendation by TipRanks Feb 15 7:02am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (SYK), SAGE Therapeutics (SAGE) and Healthcare Services (HCSG) by TipRanks Feb 15 6:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Feb 14 9:55pm ET Stryker Earns ‘Buy’ Rating on Sustained Procedure Volume and Strategic ASC Dominance by TipRanks Feb 01 7:56am ET Stryker price target raised to $360 from $315 at Canaccord by TipRanks Jan 31 10:10am ET Stryker price target raised to $360 from $345 at RBC Capital by TipRanks Jan 31 9:55am ET Stryker Corporation: A Stable Hold Amidst Strong Financial Performance and Fair Valuation by TipRanks Jan 31 9:55am ET Early notable gainers among liquid option names on January 31st by TipRanks Jan 31 9:53am ET UPS downgraded, Stryker upgraded: Wall Street’s top analyst calls by TipRanks Jan 31 9:38am ET Stryker price target raised to $345 from $300 at Deutsche Bank by TipRanks Jan 31 9:16am ET Stryker’s Strong Q4 Performance and Growth Prospects Warrant a Buy Rating by TipRanks Jan 31 9:15am ET Stryker price target raised to $362 from $340 at Citi by TipRanks Jan 31 9:06am ET Stryker price target raised to $345 from $320 at Morgan Stanley by TipRanks Jan 31 9:03am ET Stryker price target raised to $345 from $330 at Truist by TipRanks Jan 31 8:56am ET Stryker price target raised to $372 from $341 at Barclays by TipRanks Jan 31 8:52am ET Stryker price target raised to $375 from $360 at Piper Sandler by TipRanks Jan 31 8:47am ET Stryker price target raised to $348 from $345 at Roth MKM by TipRanks Jan 31 8:31am ET Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Praxis Precision Medicines (PRAX) and Thermo Fisher (TMO) by TipRanks Jan 31 8:20am ET Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Cencora (COR) by TipRanks Jan 31 8:05am ET Stryker’s Stock Buy Rating: Anticipating Strong Financial Performance and Market Outperformance by TipRanks Jan 31 7:34am ET Stryker price target raised to $365 from $322 at TD Cowen by TipRanks Jan 31 7:25am ET Stryker upgraded to Buy from Hold at Canaccord by TipRanks Jan 31 7:13am ET Stryker price target raised to $353 from $325 at BTIG by TipRanks Jan 31 7:10am ET Analysts’ Top Healthcare Picks: Stryker (SYK), HCA Healthcare (HCA) by TipRanks Jan 31 7:08am ET Stryker price target raised to $367 from $319 at Baird by TipRanks Jan 31 6:30am ET Stryker price target raised to $364 from $336 at Wells Fargo by TipRanks Jan 31 5:50am ET Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Vertex Pharmaceuticals (VRTX) and Neurocrine (NBIX) by TipRanks
No recent news articles are available for SYK
No recent press releases are available for SYK
SYK Financials
1-year income & revenue
Key terms
Ad Feedback
SYK Forecasts
analyst rating
- buy
- hold
- sell
We're sorry, but this
information is
temporarily unavailable.
1-year stock price forecast
SYK Competitors
$ Market cap P/E ratio $ Price 1d change 52-week range
